EA200300152A1 - Фармацевтический препарат сальметерола и пропионата флутиказона - Google Patents

Фармацевтический препарат сальметерола и пропионата флутиказона

Info

Publication number
EA200300152A1
EA200300152A1 EA200300152A EA200300152A EA200300152A1 EA 200300152 A1 EA200300152 A1 EA 200300152A1 EA 200300152 A EA200300152 A EA 200300152A EA 200300152 A EA200300152 A EA 200300152A EA 200300152 A1 EA200300152 A1 EA 200300152A1
Authority
EA
Eurasian Patent Office
Prior art keywords
salmeterol
propionate
fluticazone
pharmaceutical preparation
published
Prior art date
Application number
EA200300152A
Other languages
English (en)
Inventor
Доналд Херберт Хорстман
Клер Джулия Мэйден
Original Assignee
Глаксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глаксо Груп Лимитед filed Critical Глаксо Груп Лимитед
Publication of EA200300152A1 publication Critical patent/EA200300152A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatment Of Water By Ion Exchange (AREA)

Abstract

Настоящее изобретение относится к применению комбинаций сальметерола и пропионата флутиказона для лечения хронической обструктивной болезни легких.Отчет о международном поиске был опубликован 2002.08.08.
EA200300152A 2000-08-31 2001-08-31 Фармацевтический препарат сальметерола и пропионата флутиказона EA200300152A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22938100P 2000-08-31 2000-08-31
PCT/GB2001/003928 WO2002017894A2 (en) 2000-08-31 2001-08-31 Pharmaceutical formulation of salmeterol and fluticasone propionate

Publications (1)

Publication Number Publication Date
EA200300152A1 true EA200300152A1 (ru) 2003-08-28

Family

ID=22860986

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300152A EA200300152A1 (ru) 2000-08-31 2001-08-31 Фармацевтический препарат сальметерола и пропионата флутиказона

Country Status (24)

Country Link
US (1) US20040009963A1 (ru)
EP (1) EP1313484A2 (ru)
JP (1) JP2004507494A (ru)
KR (1) KR20030031997A (ru)
CN (1) CN1449288A (ru)
AP (1) AP2003002753A0 (ru)
AR (1) AR030516A1 (ru)
AU (1) AU2001284236A1 (ru)
BG (1) BG107596A (ru)
BR (1) BR0113555A (ru)
CA (1) CA2420532A1 (ru)
EA (1) EA200300152A1 (ru)
EC (1) ECSP034487A (ru)
HU (1) HUP0303755A2 (ru)
IL (1) IL154403A0 (ru)
MA (1) MA25834A1 (ru)
MX (1) MXPA03001752A (ru)
NO (1) NO20030899L (ru)
OA (1) OA12370A (ru)
PE (1) PE20020387A1 (ru)
PL (1) PL365582A1 (ru)
SK (1) SK2302003A3 (ru)
WO (1) WO2002017894A2 (ru)
ZA (1) ZA200301475B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0106031D0 (en) * 2001-03-12 2001-05-02 Glaxo Group Ltd Use
WO2004028545A1 (en) * 2002-09-25 2004-04-08 Astrazeneca Ab A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
WO2005013963A1 (en) * 2003-08-06 2005-02-17 Galephar M/F Advantageous combinations for inhalation of nacystelyn and bronchodilators
TR200907913A2 (tr) * 2009-10-20 2011-05-23 Bi̇lgi̇ç Mahmut İnhalason yolu ile alınmak üzere kuru toz formunda farmasötik bileşim
TR200909791A2 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Salmeterol ve flutikazon içeren farmasötik bileşim@
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
TR201000681A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut İnhalasyon yoluyla alınan kuru toz formülasyonları.
US10105316B2 (en) 2012-07-05 2018-10-23 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising muscarinic receptor antagonist
WO2014007772A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
WO2014007781A2 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions
WO2014177519A1 (en) * 2013-04-29 2014-11-06 Sanofi Sa Inhalable pharmaceutical compositions and the inhaler devices containing them
MA41378A (fr) * 2015-01-20 2017-11-28 Teva Branded Pharmaceutical Prod R & D Inc Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol
WO2024033624A1 (en) * 2022-08-08 2024-02-15 Verona Pharma Plc Ensifentrine (rpl-554) for the treatment of moderate chronic obstructive pulmonary disease (copd)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
GB9808802D0 (en) * 1998-04-24 1998-06-24 Glaxo Group Ltd Pharmaceutical formulations
GB9924992D0 (en) * 1999-10-21 1999-12-22 Glaxo Group Ltd Pharmaceutical aerosol formulations
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate

Also Published As

Publication number Publication date
SK2302003A3 (en) 2003-08-05
US20040009963A1 (en) 2004-01-15
IL154403A0 (en) 2003-09-17
WO2002017894A2 (en) 2002-03-07
BG107596A (bg) 2004-01-30
ECSP034487A (es) 2003-03-31
OA12370A (en) 2004-03-19
MXPA03001752A (es) 2003-06-04
CA2420532A1 (en) 2002-03-07
AP2003002753A0 (en) 2003-06-30
EP1313484A2 (en) 2003-05-28
PL365582A1 (en) 2005-01-10
WO2002017894A3 (en) 2002-08-08
NO20030899L (no) 2003-04-28
JP2004507494A (ja) 2004-03-11
AR030516A1 (es) 2003-08-20
AU2001284236A1 (en) 2002-03-13
HUP0303755A2 (hu) 2004-04-28
CN1449288A (zh) 2003-10-15
PE20020387A1 (es) 2002-06-24
BR0113555A (pt) 2003-07-22
ZA200301475B (en) 2004-05-24
MA25834A1 (fr) 2003-07-01
KR20030031997A (ko) 2003-04-23
NO20030899D0 (no) 2003-02-26

Similar Documents

Publication Publication Date Title
EA200500715A1 (ru) Новые лекарственные средства для лечения хронического обструктивного заболевания лёгких
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
BR0008699A (pt) Combinações de formoterol e furoato demometasona para asma
BR0008276A (pt) Combinações de formoterol e propionato de fluticasona para asma
DE60120936D1 (de) Behandlung von atemerkrankungen
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
EA200300152A1 (ru) Фармацевтический препарат сальметерола и пропионата флутиказона
EA200000608A1 (ru) Предотвращение и лечение амилоидогенного заболевания
EA200300788A1 (ru) Производные замещенных алкиламинов и их применение
CY1106357T1 (el) Παραγωγα αδαμαντανιου για τη θepαπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
EA200200739A1 (ru) Пиримидинкарбоксамиды, используемые в качестве ингибиторов изосимов pde4
ITMI20000312A0 (it) Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva
SE9800836D0 (sv) New Compounds
EA199900778A1 (ru) ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ И ИХ ИСПОЛЬЗОВАНИЕ ДЛЯ ИНГИБИРОВАНИЯ β-АМИЛОИДНОГО ПЕПТИДА
EA200500782A1 (ru) Лечение геморрагического шока
NL300243I2 (nl) Proteïne formuleringen.
EA200401114A2 (ru) Замещённые гидроксиэтиламины
ATE419872T1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
EA200201276A1 (ru) Производные арилметиламина для использования в качестве ингибиторов триптазы
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
EA200200875A1 (ru) Пролекарства производных имидазопиридина
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
NO20012831D0 (no) Diazepinoindoler for behandling av kronisk obstruktiv lungesykdom
BG106748A (en) Method and compositions for treating pulmonary diseases
EA200500865A1 (ru) Синергетическая комбинация, включающая рофлумиласт и r,r-формотерол